Are the angiotensin-converting enzyme gene and activity risk factors for stroke?

Arquivos de Neuro-Psiquiatria

Volumn 64, Issue 2 A, 2006, Pages 211-216

  Dikmen, Miris ^a   Günes, Hasan Veysi ^a   Degirmenci, Irfan ^a   Özdemir, Gazi ^a   Basaran, Ayse ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

ACE gene; PCR; Polymorphism; Stroke

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE ACTIVITY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; STROKE; VASCULAR DISEASE;

EID: 33745516926     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2006000200008     Document Type: Article

References (36)

1. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996;93:1630-1633.
2. Hassan A, Markus HS. Genetics and ischemic stroke. Brain 2000;123:1784-812.
3. Doi Y, Yoshinari M, Yoshizumi H, Ibayashi S, Wakisaka M, Fujishima M. Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. Atherosclerosis 1997;132:145-150.
4. Sharma P. Meta-analysis of the ACE gene in ischemic stroke. J Neurol Neurosurg Psychiatry 1998;64:227-230.
5. Catto A, Carter AM, Barrett JH, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and cere b rovascular disease. Stroke 1996;27:435-440.
6. Corvol, P, Soubrier F, Jeunemaitre X. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Pathol Biol (Paris) 1997;45:229-239.
7. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts trought the years. Hypertension 1990;16:363-370.
8. th Ed. Ankara: Feryal Matbacilik 1990;2860-2886.
9. th Ed. Stanford: Appleton and Lange 1997;425-436.
10. Hubert C, Houot AM, Corvol P, Soubrier F. Stru c t u re of the angiotensin I-converting enzyme gene. J Biol Chem 1991;266:15377-15383.
11. Ehlers, MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-5317.
12. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism. Circulation 1996;94:236-239.
13. Sharma P, Carter ND, Barley J, Brown MN. Molecular aproach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens 1994;8:645-648.
14. Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;26:1329-1333.
15. Zee RYL, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K. P rospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and risk of stroke. Circulation 1999;99:340-343.
16. Pfohl M, Fetter M, Koch M, Barth CM, Weib R, Häring HU. Association between angiotensin I-converting enzyme genotypes extracranial artery stenosis and stroke Atherosclerosis 1998;140:161-166.
17. Notsu Y, Nabika T, Park HY, Masuda J, Kobayashi S. Evaluation of genetic risk factors for silent brain infarction. Stroke 1999;30:1881-1886.
18. The sixth report of the joint national committee on prevention, detection, evulation and treatment of the high blood pressure. Arch Intern Med 1997;99:1585-1595.
19. Günes HV, Ata N, Degirmenci I, et al. Frequency of angiotensin converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract 2004;58:838-843.
20. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997;99:1585-1595.
21. Margaglione M, Celentano E, Grandone E, et al. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscl Thromb Vasc Biol 1996;16:304-309.
22. Karagiannis A, Balaska K, Tziomalos K, Tokalaki-Nikolaidou L, Papayeoryiou A, Zamboulis C. Lack of an association between angiotensin- converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur Neurol 2004;51:148-152.
23. Kostulas K, Huang WX, Crisby M, et al. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischemic stroke and carotid stenosis. Eur J Clin Invest 1999;29:478-483.
24. Robert YL, Zee BDS, Paul M, et al. Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 1999;99:340-343.
25. Harrap SB, Tzourio C, Cambien F, et al. The ACE I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 2003;42:297-303.
26. Araz M, Yilmaz N, Gungor K, Okan V, Kepekci Y, Aynacioglu SA. Angiotensin-converting enzyme gene polymorphism and micro v a scular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 2001;54:95-104.
27. Kiema TR, Kauma H, Rantala AO, et al. Variation at the angiotensinconverting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996;28:1070-1075.
28. Syrjane J, Teppo AM, Valtonen VV, et al. Acute phase response in cerebral infarction. J Clin Pathol 1989;42:63-68.
29. Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocysteine ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069.
30. Harmon DL, Doyle RM, Meleady R, et al. Genetic analysis of the thermolabile variant of 5,10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscl Thromb and Vasc Biol 1999;19:208-211.
31. Morita H, Kurihara H, Tsubaki, et al. Methylenetetrahydrofolate re d u ctase gene polymorphism and ischemic stroke in Japanese. Arterioscl Thromb Vasc Biol 1998;18:1465-1469.
32. Tan NC, Venketasubramanian N, Saw SM, et al. Hyperhomocysteinemia and risk of ischemic stroke among young Asian adults. Stroke 2002;33:1956-1962.
33. Madonna P, Stefano V, Coppola A, et al. Hyperhomocysteinemia and other inherited pro t h rombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-56.
34. Ridker PM, Stampfer MJ, Rifai N. Novel risk factor for systemic atherosclerosis. JAMA 2001;285:2481-2485.
35. Kang S, Passen EL, Ruggie N, et al. Thermolabile defect of methylenetet rahydrofolate reductase in coronary artery disease. Circulation 1993;88:1463-1469.
36. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle- aged british men. Lancet 1995;25:1395-1398.\